Menlo Therapeutics, Inc. (MNLO) has 5 open-market insider trades by 5 insiders since 2018. The most active filer is Perceptive LIFE Sciences Master FUND Ltd., Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Perceptive LIFE Sciences Master FUND Ltd. via Joseph Edelman | Dir10% Owner | — | 1 | $10.0M | 2020-06-09 |
| Albert Cha | Dir | — | 1 | $5.0M | 2018-01-29 |
| venBio Global Strategic Fund II L.P. | 10% Owner | — | 1 | $4.5M | 2018-01-29 |
| James F. Watson | — | — | 1 | $3.8M | 2018-07-24 |
| Remeditex Ventures LLC | 10% Owner | — | 1 | $1.7M | 2018-01-29 |
| Vivo Capital Fund VIII, L.P. via Albert Cha | 10% Owner | — | 0 | — | 2018-01-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Perceptive LIFE Sciences Master FUND Ltd. | Director & 10% Owner | Buy | $10.0M | 2020-06-09 |
| James F. Watson | — | Sell | $3.8M | 2018-07-24 |
| Remeditex Ventures LLC | 10% Owner | Buy | $1.7M | 2018-01-25 |
| Albert Cha | Director | Buy | $5.0M | 2018-01-25 |
| venBio Global Strategic Fund II L.P. | 10% Owner | Buy | $4.5M | 2018-01-25 |
Companies that share insiders with MNLO, and sector peers with recent insider buying. Related by who files, not by how the stocks move.